For the quarter ending 2026-03-31, OPK made $124,196K in revenue. -$54,848K in net income. Net profit margin of -44.16%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenues | 124,196 | 148,451 | 151,669 | 156,807 |
| Cost of goods and services sold-Service | 56,143 | 63,173* | 80,402 | 82,383 |
| Cost of goods and services sold-Product | 22,298 | 23,995* | 21,374 | 25,022 |
| Selling, general and administrative | 48,607 | 50,515 | 53,804 | 59,597 |
| Research and development | 29,199 | 32,772 | 30,078 | 30,342 |
| Contingent consideration | - | 0* | - | - |
| Amortization of intangible assets | 18,966 | 19,054 | 19,531 | 19,444 |
| Loss on sale of assets | - | 2,742* | 101,576 | - |
| Total costs and expenses | 175,213 | 186,767 | 103,613 | 216,788 |
| Operating loss | -51,017 | -38,316 | 48,056 | -59,981 |
| Interest income | 3,007 | 3,820 | 3,023 | 3,287 |
| Interest expense | 10,939 | 11,311 | 11,358 | 70,327 |
| Fair value changes of derivative instruments, net | -298 | -134 | -38 | 16 |
| Other income (expense), net | -1,709 | -960 | 1,748 | -35,515 |
| Other expense, net | -9,939 | -8,585 | -6,625 | -102,539 |
| Loss before income taxes and investment losses | -60,956 | -46,901 | 41,431 | -162,520 |
| Income tax benefit | -6,110 | -15,661 | 19,797 | -14,079 |
| Net loss before investment losses | -54,846 | -31,240 | 21,634 | -148,441 |
| Loss from investments in investees | -2 | -17 | -3 | 0 |
| Net loss | -54,848 | -31,257 | 21,631 | -148,441 |
| Basic EPS | -0.07 | -0.041 | 0.03 | -0.19 |
| Diluted EPS | -0.07 | -0.046 | 0.03 | -0.19 |
| Basic Average Shares | 758,876,415 | 767,792,335 | 777,154,808 | 788,006,992 |
| Diluted Average Shares | 758,876,415 | 685,472,422 | 779,919,259 | 788,006,992 |
OPKO HEALTH, INC. (OPK)
OPKO HEALTH, INC. (OPK)